JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesCMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytesMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainAnimal Models for Progressive Multifocal LeukoencephalopathyThe importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathyProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.Brain Biopsy Is More Reliable than the DNA test for JC Virus in Cerebrospinal Fluid for the Diagnosis of Progressive Multifocal Leukoencephalopathy.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication ratePersistence and pathogenesis of the neurotropic polyomavirus JCInterplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.The rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.Molecular biology and immunoregulation of human neurotropic JC virus in CNS.Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.Lack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System.Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.JC virus detection and JC virus-specific immunity in natalizumab-treated multiple sclerosis patients.Natalizumab and progressive multifocal leucoencephalopathy.An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathyDetection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.Immune surveillance and response to JC virus infection and PML.Update on progressive multifocal leukoencephalopathy.The human JC polyomavirus (JCPyV): virological background and clinical implications.Targeting integrins and adhesion molecules to combat inflammatory bowel disease.Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.Immunology of progressive multifocal leukoencephalopathy.Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.Progressive multifocal leukoencephalopathy and black fungus in a patient with rheumatoid arthritis without severe lymphocytopenia.JC Virus Infection After Transplantation: Beyond the Classic Progressive Multifocal Leukoencephalopathy?Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate.BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy.Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy.Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches?Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
P2860
Q21285083-9097BB7B-E647-4513-A322-3890F3C31AE9Q24599841-CBE77078-26B9-4886-A28C-FF054E3C9ACAQ24619923-B4F26745-97A2-4E49-9EF3-CE117976703CQ26853218-6FCE7595-D4B1-498D-AE9C-B8ED96FDEE17Q26859307-FAC61763-04C1-4524-BF97-5FB6114185FCQ30235523-2071B102-0FC5-43CE-85A7-3206AFCBE193Q30354301-EB1F1681-9B7B-4A5C-9F99-934BA1FDEC71Q32182100-BEACE522-701B-421D-8CB8-C7297FA79A4AQ33893285-79B5FC21-B2E2-43EC-A6C1-721886FF2F31Q34178250-1329E99D-4273-4584-9DB5-DB83856E74FBQ34459843-69317828-B940-4D6E-BB89-8E1A63268E68Q34545686-F35328C8-6D90-4F67-B680-879C3605B28AQ34629128-B4585952-8667-4880-B5F8-7840CF7CAD02Q34638628-F9765911-D8B6-49E2-85AD-BD1A23D295CAQ35675602-5107C6C4-6248-4AC7-B47A-666BF1985180Q35864067-235FD29B-26F4-4761-A17F-320E38B52FBAQ36153492-C04A7B24-5260-48D6-87FC-4843DDBE1502Q36384476-23BCCAB4-40F8-4EF6-A005-A04869FBB688Q36572168-E946D782-F5FD-43CE-8E6E-E7E0B91C6BE7Q36622383-9AFDDA24-061F-4E0D-B5B1-41480FF69776Q36766174-917EDD2D-2B47-4153-8938-C60CC8D90EB1Q36890313-92EC1F37-E30F-40A8-94A4-69E630AE6FFDQ36942417-CD398218-E414-4C4D-9EDA-E4439BFF5D8DQ37492573-23BA3C80-8032-48AC-AFC6-E729B9318155Q37678580-E72FD7E3-2FE0-43CE-B064-DC4920196A9DQ38044681-275A123F-8C0C-4027-8603-9D34A127CF22Q38115572-0474CCA9-8743-44FE-BB84-24C47D8BC0B9Q38248635-8D4C58B8-E326-48BC-8572-838DA0010868Q38261176-1A1A0C63-8C0F-436B-998B-E93054A45F80Q38367755-156AB101-F80B-49F5-9B6A-28491F67939EQ38462168-A726C2D0-6639-4D43-AF60-7F0C6EA3295CQ38619288-CEFFB9F9-B792-4252-9D5D-C8E7ED6B0826Q40271075-AEB3B914-F2C2-498C-A6F4-6CECA59F7493Q41880740-F8B278AF-B301-4733-AF0A-7F89AC4412C1Q41924854-FE15EBB0-44B7-4DB2-964D-94BBF630D93EQ42702341-0F600EA0-7FA7-4759-A1D1-84834292897EQ43132534-1E090F3C-D733-41C6-A3B5-270B3820A80BQ43649915-E0067266-3437-45CF-93A2-36EC6125AADCQ48468772-527B28BA-6CDF-4DBF-8DE4-D0460F4DE4F6Q55481186-A543FDA2-4199-4DB9-888B-592D04DBE0E5
P2860
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
JC virus-specific cytotoxic T ...... ultifocal leukoencephalopathy.
@ast
JC virus-specific cytotoxic T ...... ultifocal leukoencephalopathy.
@en
type
label
JC virus-specific cytotoxic T ...... ultifocal leukoencephalopathy.
@ast
JC virus-specific cytotoxic T ...... ultifocal leukoencephalopathy.
@en
prefLabel
JC virus-specific cytotoxic T ...... ultifocal leukoencephalopathy.
@ast
JC virus-specific cytotoxic T ...... ultifocal leukoencephalopathy.
@en
P2860
P1433
P1476
JC virus-specific cytotoxic T ...... multifocal leukoencephalopathy
@en
P2093
I J Koralnik
N L Letvin
P2860
P304
P356
10.1128/JVI.75.7.3483-3487.2001
P577
2001-04-01T00:00:00Z